Commercialization advisory board

The VCU Commercialization Advisory Board includes industry experts, early-stage investors and entrepreneurs who provide guidance and recommendations for critical commercialization and investment decisions.

The board reviews technologies and judges inventors’ presentations based on various factors, including patentability, stage of development, unmet market need, industry feedback and societal impact.

Monique Bennett

Senior Life Sciences Strategist

BioHealth Innovation

Expertise: Non-dilutive funding and market research

Reinhold Brand

Reinhold Brand

President (retired)

Evonic USA

Expertise: Material sciences & specialty chemicals

Kevin Corby

Research and development director (retired)

DuPont

Expertise: Industrial chemistry

Alex Euler

Alex Euler

Investment director

CIT Gap Fund

Expertise: Life sciences

Bruce Ferris

Managing partner

SPARK Product Development LLC

Expertise: Product design & design for manufacturing

Gerard Eldering

President

InnovateTech Ventures

Expertise: University Commercialization Startups

Tracey Greene

Founding executive director

Charlottesville Angel Network

Expertise: Technology innovation, entrepreneurship, and early stage investments

Debbie Irwin

Managing Director

Lighthouse Labs RVA

Expertise: Entrepreneurship, early stage start-up support

Glen Kelley

Principal Consultant

Limpidity Biosciences LLC

Expertise: Drug and Drug/device product development; Regulatory Affairs; Intellectual Property

Mark Lambert Headshot

Mark Lambert

Founder

VArtisans

Expertise: Virtual reality & film industry

Chris Little Headshot

Chris Little

Founder

SingleStone

Expertise: Software

Sean Mallon

VP, Commercialization

Virginia Innovation Partnership Corporation

Expertise: Technology startups, early stage investing

Albine Martin

Entrepreneur-in-Residence, JHU

BioHealth Innovation

Expertise: Biotechnology and diagnostics

William McPheat Headshot

William McPheat

Principle scientist (retired)

AstraZeneca

Expertise: Pharma & cardiovascular drug development

Matthew Miessau

Associate

Epidarex Capital

Expertise: Life sciences

John Newby Headshot

John Newby

CEO

Virginia Bio

Expertise: Life sciences, patent law, and government

Kaitlyn L. O'Connor, Esq.

Partner

Nixon Gwilt Law

Dan O'Korn

Partner

Hutchison PLLC

Expertise: Life Sciences

James Pannucci

VP - Entrepreneurship

Activation Capital

Expertise: Business of Science

Richard Pellegrino

Chief Research and Development Officer

Grenova

Expertise: Medical devices

Brandon J. Price

Independent Advisor to Entrepreneurial Ventures

Professor of Entrepreneurship, Panamerican University Colleges of Business and Engineering

Expertise: Biotechnology (biologic drugs and medical devices)

Kirsten Rieth

Director, Strategy and Innovation

RTI Innovation Advisors

Expertise: Technology commercialization & market strategy

Dennis Schafer

Dennis Schafer

Director

Life Science Management

Expertise: Pharma & serial entrepreneurship

William Weber

VP and general manager (retired)

DuPont

Expertise: Chemical industry

Tony Wilkins, CFA

Private Investor

Expertise: Start-ups, angel and VC investments

Vida Williams

Advanced analytics solution lead

SingleStone

Expertise: Big data & data science